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A Campylobacter fetus subsp. venerealis-specific 5 Taq nuclease PCR assay using a 3 minor groove binder-
DNA probe (TaqMan MGB) was developed based on a subspecies-specific fragment of unknown identity (S.
Hum, K. Quinn, J. Brunner, and S. L. On, Aust. Vet. J. 75:827–831, 1997). The assay specifically detected four
C. fetus subsp. venerealis strains with no observed cross-reaction with C. fetus subsp. fetus-related Campylobacter
species or other bovine venereal microflora. The 5 Taq nuclease assay detected approximately one single cell
compared to 100 and 10 cells in the conventional PCR assay and 2,500 and 25,000 cells from selective culture
from inoculated smegma and mucus, respectively. The respective detection limits following the enrichments
from smegma and mucus were 5,000 and 50 cells/inoculum for the conventional PCR compared to 500 and 50
cells/inoculum for the 5 Taq nuclease assay. Field sampling confirmed the sensitivity and the specificity of the
5 Taq nuclease assay by detecting an additional 40 bulls that were not detected by culture. Urine-inoculated
samples demonstrated comparable detection of C. fetus subsp. venerealis by both culture and the 5 Taq nuclease
assay; however, urine was found to be less effective than smegma for bull sampling. Three infected bulls were
tested repetitively to compare sampling tools, and the bull rasper proved to be the most suitable, as evidenced
by the improved ease of specimen collection and the consistent detection of higher levels of C. fetus subsp.
venerealis. The 5 Taq nuclease assay demonstrates a statistically significant association with culture (2 
29.8; P < 0.001) and significant improvements for the detection of C. fetus subsp. venerealis-infected animals
from crude clinical extracts following prolonged transport.
Bovine venereal campylobacteriosis or vibriosis is a major
cause of abortion and infertility in cattle and is one of the most
important bovine venereal diseases in Australia (6). The dis-
ease is caused by Campylobacter fetus subsp. venerealis and is
spread by infected bulls during servicing, by contaminated se-
men, or between bulls (41). Campylobacteriosis is an Office
International des Epizooties list B notifiable disease that is
considered to have socioeconomic and/or public health impli-
cations and is thus significant in the international trade of
animals and animal products. In addition, international semen
export guidelines require that bulls be C. fetus subsp. venerealis
negative. Symptoms in female cattle include irregular estrus
cycles, infertility through uterine infection, and early embry-
onic death, while bulls are asymptomatic carriers (6). The
symptoms of campylobacteriosis are very similar to those of
trichomoniasis (caused by the protozoan Tritrichomonas fetus),
and these venereal diseases tend to occur in areas with exten-
sive cattle management and natural breeding, such as western
North America, Australia, Africa, and Latin America (11). In
Australia, it has been estimated that vibriosis causes significant
reproductive wastage in infected beef and dairy herds and
represents a large economic loss for producers, particularly in
the first year of infection, where gross margins can be reduced
by as much as 66% (19). When the disease becomes established,
gross margins may be 36% below those of noninfected herds (19).
Similarly, in Argentina, bovine venereal diseases are considered
to be causes of low reproductive efficiency with severe economic
losses (5). Several killed bacterial campylobacteriosis vaccines
are available, e.g., Vibrovax (Pfizer Animal Health, Australia);
Vibrio-Lepto-5 (Boehringer Ingelheim Vetmedica, Inc.); Bio-
abortogen-H, Biogenesis, and Repropolivac (San Jorge Bago,
Argentina); and Campylobacter (Vibrio) fetus vaccine (Onder-
stepoort Biological Products Ltd., South Africa) (9, 10), and such
vaccines are considered the most effective means of managing the
disease.
The diagnosis of infection is by the direct isolation of the
causative agent by selective culture from semen, preputial
smegma, or vaginal mucus (20, 31) or through the detection of
an immune response in cervico-vaginal mucus by using an
enzyme linked immunosorbent assay (ELISA) (23). Several
methods for the collection of preputial smegma and vaginal
mucus have been investigated in order to improve the reliabil-
ity of selective culture-based diagnostic procedures or ELISA.
These procedures have included preputial washes, scrapes
(55), mucus swabs, blotting (23), and the commonly used
scrape/aspiration methods with a pipette (26, 41, 55). The use
of swabs and blotting has been limited to female cattle. A
comparison of three collection methods for preputial smegma
(scraping, aspiration, and washing) demonstrated that scraping
with a specialized tool that was developed for the collection of
preputial smegma for Tritrichomonas fetus culture reduced
contaminant levels and improved isolation rates compared to
those for aspiration and washing (55). Both aspiration and
washing require manipulation of a syringe or bulb as well as the
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pipette, requiring at least two people during the collection of
diagnostic specimens.
The traditional culture and ELISA diagnostic procedures
present with sensitivity and specificity limitations. The ELISA
is known to produce false-positive and false-negative results,
and a high percentage of C. fetus subsp. venerealis strains are
susceptible to polymyxin B, an antibiotic used in all Cam-
pylobacter selective media and transport enrichment media
(TEM) (20, 26). Campylobacter colonies from preputial scrapes
and vaginal mucus are visible within 48 h in a microaerobic
environment, and the slow-growing C. fetus subsp. venerealis is
readily overgrown by a range of microbes, leading to inaccu-
rate diagnoses (31). These methods are not very sensitive or
specific, and discrimination between C. fetus subsp. venerealis
and the morphologically, phenotypically, and genetically simi-
lar C. fetus subsp. fetus is not reliable (57). A direct immuno-
fluorescence test (DIFT) has been developed and applied to
the detection of C. fetus, and although not widely evaluated, it
may present with false-positive results due to nonspecific flu-
orescence and the inability to differentiate C. fetus subspecies
(38). C. fetus subsp. fetus occurs mainly in the intestinal tracts
of cattle and sheep and causes only sporadic abortion in these
animals (50). Conversely, C. fetus subsp. venerealis is highly
adapted to the genital tract of cattle and cannot survive in the
bovine intestine (4). It is thus essential to identify C. fetus
subspecies in the diagnosis of bovine venereal diseases. Mo-
lecular methods such as PCR (22), amplified fragment length
polymorphism (57), and pulsed-field gel electrophoresis (17,
44) have been used to discriminate between the two Campylo-
bacter fetus subspecies. However, PCR has not been routinely
applied for the diagnosis of bovine venereal campylobacterio-
sis and field studies continue to rely upon either selective
culture (20), ELISA (21), or DIFT (38).
Although the isolation and identification of C. fetus subsp.
venerealis appears to be difficult, the adaptation of sensitive
molecular methods for direct detection in clinical samples has
not been forthcoming. In comparison to conventional PCR
techniques, 5 Taq nuclease assays are highly sensitive and
specific and the amount of target DNA in the assay can also be
accurately quantified (37). The implementation of 5 Taq nu-
clease assays has improved the detection of a wide range
of pathogenic organisms, including Salmonella enterica (18),
pathogenic Leptospira spp. (51), Campylobacter jejuni (43),
Actinobacillus pleuropneumoniae (3), and Mycobacterium avium
subsp. paratuberculosis (28). Minor groove binder (MGB)
probes demonstrate higher specificities and sensitivities than
non-MGB probes in 5 Taq nuclease assays (30) and thus are
highly suited for routine diagnostic applications as demon-
strated for the detection of bovine retroviruses (34, 35). This
study describes the optimization of sampling, transport, and
processing protocols for the diagnosis of bovine venereal
campylobacteriosis by using a novel 5 Taq nuclease PCR assay
utilizing a 3 TaqMan MGB probe.
MATERIALS AND METHODS
Bacterial and protozoan culture. Isolates of several Campylobacter species
were obtained from the Animal Research Institute, Department of Primary
Industries and Fisheries (DPI&F), from the American Type Culture Collection,
and from the National Collection of Type Cultures (Table 1). Campylobacter
strains were grown at 37°C in brain-heart infusion broth (Oxoid), 0.2% yeast
extract, 0.07% Bacto agar for between 1 and 3 days. Tritrichomonas fetus was
grown at 37°C in 1.25% neutralized liver digest, 0.5% tryptose, 0.15% Bacto agar,
50% sterile heat-inactivated bovine serum, 0.1% P/S solution (0.75% penicillin
and 0.082% streptomycin). Pseudomonas aeruginosa and Proteus vulgaris were
grown at 37°C on blood agar plates for 24 h. Neospora caninum tachyzoites were
cultured in Vero cells as previously described (14).
Animal sampling. Three techniques were evaluated for the collection of
smegma from bulls and the collection of vaginal mucus from female cattle.
Collection techniques were evaluated on the basis of ease of use for the veter-
inarians, lack of adverse impact upon the animals, and suitability of the material
gained for assay and culture.
Preputial smegma samples were collected from eight bulls by using sterile
pipettes, swabs, or bull raspers. The bulls were restrained in a veterinary crush
during the collection procedures. A sterile pipette (10-mm internal diameter,
with a beveled edge) was gently scraped along the surface of the penis and
internal prepuce near the fornix, with gentle aspiration being applied with an
attached bulb or syringe. The collected smegma was rinsed into approximately 5
ml sterile phosphate-buffered saline (PBS) or physiological saline. A sterile
McCullough uterine mare swab (Minitube Australia Pty Ltd.) was gently scraped
along the surface of the penis and internal prepuce near the fornix. The collected
smegma was expressed into approximately 5 ml sterile PBS or physiological
saline. A bull rasper (polyethylene, 60 cm long with a 75-mm-long, 8-mm-
diameter corrugated scraper head with a 1.5-mm collection bore attached to
6-mm-diameter tubing with a 1.5-mm internal diameter, similar to those pro-
duced by Elastecnica, Argentina; based on the original design that was described
previously [52]) was gently scraped along the surface of the penis and internal
prepuce near the fornix. No aspiration was necessary. The collected smegma was
rinsed into approximately 5 ml sterile PBS or physiological saline.
Vaginal mucus samples were collected from eight cows by using artificial
insemination pipettes, swabs, or bull raspers during restraint in a veterinary
crush. A sterile artificial insemination infusion pipette was inserted so that the
anterior end reached the cervix. Gentle suction was applied by using a rubber
bulb while moving the pipette gently backwards and forwards. The pipette was
removed, and the collected mucus was rinsed into approximately 5 ml sterile
physiological saline. A sterile 15-cm swab, held by sterile forceps, was inserted so
that the anterior end reached the cervix. The swab was gently moved backwards
and forwards while being rotated to saturate the head with mucus. The swab was
removed, and the collected mucus was expressed into approximately 5 ml sterile
physiological saline. A bull rasper was inserted so that the anterior end reached
the cervix. The rasper was moved gently backwards and forwards. No aspiration
was necessary. The rasper was removed, and the collected mucus was rinsed into
approximately 5 ml sterile physiological saline.
TABLE 1. Reference species and isolates used in this study
Species Strain Source
C. fetus subsp. venerealis 98-109383 Field isolate (DPI&F)
C. fetus subsp. venerealis 19438 ATCC
C. fetus subsp. venerealis Biovar venerealis Pfizer Animal Health,
Australia
C. fetus subsp. venerealis Biovar intermedius Pfizer Animal Health,
Australia
C. fetus subsp. fetus 98-118432 Field isolate (DPI&F)
C. fetus subsp. fetus 15296 ATCC
C. jejuni subsp. jejuni 11168 NCTC
Campylobacter hyointestinalis N3145 Field isolate (DPI&F)
Campylobacter sputorum
subsp. bubulus
Y4291-1 Field isolate (DPI&F)
Campylobacter coli 11353 NCTC
Tritrichomonas foetus YVL-W Field isolate (DPI&F)
T. foetus 30003 ATCC
Tetratrichomonas gallinarum 30097 ATCC
Pentatrichomonas hominis 30000 ATCC
Trichomonas vaginalis 30001 ATCC
Pseudomonas aeruginosa 27853 ATCC
Proteus vulgaris 6380 ATCC
Neospora caninum 50843 ATCC
Leptospira borgpetersenii
serovar Hardjobovis
93/94451/3 Field isolate (DPI&F)
Leptospira interrogans
serovar Pomona
Pomona CCRLa
a CCRL, WHO/FAO/OIE Collaborating Centre for Reference and Research
on Leptospirosis, Australia and Western Pacific Region.
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Urine was investigated to determine its feasibility as an alternative clinical
specimen for the diagnosis of venereal C. fetus subsp. venerealis infection in bulls.
Urine from two consecutive voids was collected in a series of sterile collection
containers following the subcutaneous administration of a diuretic (Frusemide;
Ilium Veterinary Products, Australia). The first container collected was dis-
carded as being the most likely to be heavily contaminated with fecal material,
hair, and other debris.
Diagnostic culture. Culture-based diagnosis for C. fetus subsp. venerealis was
conducted by the inoculation of 5 ml modified Weybridge medium (32) with 0.5
ml of preputial smegma in PBS or vaginal mucus in saline, followed by transport
at ambient temperatures for up to 48 h. Upon arrival at the laboratory, 100 l of
the inoculated modified Weybridge medium was plated onto Campylobacter fetus
selective medium (Skirrow’s) (49) and incubated at 37°C in a microaerobic
environment that was generated by using an anaerobic jar and a Campygen
sachet (Oxoid). The presence of C. fetus subsp. venerealis was indicated by the
presence of small (about 0.5 mm in diameter), smooth, translucent colonies
arising after 48 to 72 h, followed by microscopic confirmation of Campylobacter-
like morphology.
PCR template preparation. DNA was extracted from liquid culture, resus-
pended colonies, preputial smegma, vaginal mucus, and urine samples by using
a commercial kit (QIAamp DNA mini kit; QIAGEN) as per the manufacturer’s
protocol, except for elution of the final product in 50 l rather than 400 l.
Crude cell lysates were prepared for the 5 Taq nuclease assay by a heat lysis
method. One milliliter of the sample (preputial smegma in PBS; vaginal mucus
in saline or urine) was centrifuged for 5 min at 12,000  g, and the supernatant
was discarded. The pellet or compressed mucus was resuspended in 500 l sterile
distilled water and heated at 95°C for 10 min. The suspension was centrifuged for
30 s at 2,000  g, and the supernatant was assayed by 5 Taq nuclease assay.
PCR amplification, cloning, and conventional PCR assay. All primers used in
this study were synthesized by Proligo Australia Pty Ltd. The 142-bp C. fetus
subsp. venerealis-specific product was amplified in a 15-l reaction mixture vol-
ume by using 500 nM VenSF and VenSR primers (Table 2) (22), 1 PCR buffer
with MgCl2 (Roche Diagnostics), 200 M dNTPs, 1 U Taq DNA polymerase
(Roche Diagnostics), and 1 ng of target C. fetus subsp. venerealis DNA. The
reactions were cycled in a GeneAmp PCR system model 2700 (Applied Biosys-
tems Inc.) using the following conditions: initial denaturation at 95°C for 10 min,
30 cycles at 95°C for 20 s, annealing at 50°C for 20 s, and extension at 72°C for
2 min, with a final extension at 72°C for 10 min.
PCR assays were conducted under the same conditions using both the VenSF-
and-VenSR primer pair and MG3F-and-MG4R primer pair (Table 2), which
amplify a 960-bp C. fetus-specific product (22). Two microliters of QIAGEN
kit-purified genomic DNA (gDNA) prepared from smegma, mucus, and urine
extracts was added as template for conventional PCR assays. The presence of C.
fetus subsp. venerealis is indicated by the presence of both the 960-bp C. fetus-
specific amplicon and the 142-bp C. fetus subsp. venerealis-specific amplicon.
Amplification products were separated in 2% TBE (89 mM Tris borate, 2 mM
EDTA [pH 8]) agarose gels by using size markers (Marker XIV; Roche Molec-
ular Biochemicals, Germany) and were visualized under UV illumination by
ethidium bromide staining.
Sequencing. The 142-bp C. fetus subsp. venerealis-specific amplicon from strain
98-118432 was ligated into a cloning vector (pCR2.1, TOPO-TA cloning kit;
Invitrogen Corporation) as described in the manufacturer’s protocol. Plasmids
with inserts were sequenced using the T7 and M13 reverse primers and the
BigDye Terminator mix (Applied Biosystems, Inc.), following the manufacturer’s
protocols. Sequences were analyzed by the Griffith University DNA Sequencing
Facility (School of Biomolecular and Biomedical Science, Griffith University,
Nathan, QLD 4111, Australia) on an ABI 377 DNA sequencer.
5 Taq nuclease assay. Primer and probe combinations for 5 Taq nuclease
assay using fluorescent 3 MGB-DNA probes (synthesized by Applied Biosys-
tems, Inc.) were designed for C. fetus subsp. venerealis by using Primer Express,
version 2 (Applied Biosystems, Inc.), and BLASTn searches (http://www.ncbi
.nlm.nih.gov/BLAST/) were conducted to confirm sequence specificity. Se-
quences of primers and the probe are provided in Table 2. The 5 Taq nuclease
assay for C. fetus subsp. venerealis was conducted in a 25-l volume by using
either Platinum Quantitative PCR SuperMix-UDG (Invitrogen Life Technolo-
gies) or RealMasterMix probe mix (Eppendorf) with 900-nM CFVF and CFVR
primers, 170 nM CFVP1 fluorescent 3 MGB-DNA probe, and 5 l of either
heat-lysed cells or kit-purified DNA templates in a Corbett Rotor-Gene RG-
3000 (Corbett Research, Australia). The thermal profile was 50°C for 2 min, 95°C
for 2 min, and 45 cycles of denaturation at 95°C for 20 s, annealing at 50°C for
20 s, and extension at 72°C for 20 s. The acquisition of fluorescence occurred at
the end of each extension step. A positive result was indicated by the fluores-
cence (normalized to a no-template control) passing a threshold of 0.1. Assay
conditions were optimized by using serial dilutions of C. fetus subsp. venerealis-
purified DNA. Quantitative estimates of target cells/ml were calculated by using
a standard curve generated with either kit DNA extracts or crude cell extracts
prepared from serial dilutions of known numbers of C. fetus subsp. venerealis
isolates. All 5 Taq nuclease assays were prepared in duplicate, with cycle thresh-
old or quantitative cell estimates averaged for each sample. Inconsistently pos-
itive samples (one of two repeats) were repeated.
Sensitivity evaluation and effects of transport. C. fetus subsp. venerealis strain
98-109383 cells from 2-day-old fresh cultures were treated 1:1 with methanol to
reduce cell motility and were counted by using a hemocytometer. Serial log
dilutions of the 2-day-old C. fetus subsp. venerealis cultures were prepared at 105
cells/ml and were diluted to 1 cell/ml. These dilutions were inoculated into
smegma, mucus, and urine that were obtained from healthy animals which had
previously tested negative for both C. fetus subsp. venerealis (by selective culture
and 5 Taq nuclease assay) and T. fetus (microscopic examination of InPouchTF
cultures) (Biomed Diagnostics). The viability of the cells that were used for these
evaluations was determined by spreading 100 l of each dilution onto prepoured
Columbia sheep blood agar plates (Oxoid), and colonies were counted following
2 days of incubation at 37°C in a microaerobic environment (as described above).
Genomic DNA was extracted from the spiked specimens by using a commercial
DNA extraction kit (QIAamp DNA mini kit; QIAGEN), which was assayed by
both conventional PCR and 5 Taq nuclease assays. Inoculated specimens were
also prepared for 5 Taq nuclease assay by heat lysis. Modified Weybridge TEM
were inoculated with these laboratory-spiked specimens, as was done for diag-
nostic culture. DNA was also extracted from aliquots of inoculated TEM by using
a commercial kit (QIAamp; QIAGEN) and assayed by both 5 Taq nuclease
assay and conventional PCR assay. Selective media were inoculated from the
TEM as was done for diagnostic culture. Estimates of cell equivalents/assay or
cells/inoculum were calculated from the enumerated spiked specimens by deter-
mining equivalent cell numbers contained in the final volume used either as
template for PCR or as inoculum in cultures.
5 Taq nuclease assays were scored positive if the fluorescence (normalized to
a no-template control) passed a threshold of 0.1. A positive conventional PCR
assay required the detection of both the 960-bp, species-specific and the subspe-
cies-specific, 142-bp amplicons. Results from cultured samples were scored pos-
itive for the presence of Campylobacter-like colonies, followed by microscopic
confirmation of Campylobacter-like morphology and motility.
Sample transport was simulated by storing the inoculated TEM and animal
samples at ambient temperatures for smegma and mucus and at 4°C for urine for
up to 5 days. Samples for 5 Taq nuclease assays, conventional PCR assays, and
selective culture were processed as described above at time zero and after 2 and
5 days of storage. To examine changes in cell numbers under these storage
conditions, quantified cell estimates were compared by using 5 Taq nuclease
assay results of the 104 cells/ml-spiked samples.
Field sampling evaluation. Preputial smegma (n  249) and cervico-vaginal
mucus (n  120) specimens were collected from 369 animals originating from 38
properties throughout northeastern Australia (Queensland) by using the bull
rasper and the collection protocols described above. Specimens were assayed for C.
fetus subsp. venerealis by both diagnostic culture and 5 Taq nuclease assay. Urine
was collected (as described above) from 16 bulls whose samples were positive by
smegma 5 Taq nuclease assay and processed for 5 Taq nuclease assay testing.
A chi-square test was used to compare the distribution of positive and negative
results for the two methods of testing, culture and 5 Taq nuclease assay. The
proportions that were detected as positive by the two methods were also
compared by using a normal approximation. Mucus samples from female
cattle were also tested by using the C. fetus subsp. venerealis ELISA as
described previously (23).
TABLE 2. Primers and fluorescent 3 MGB-DNA probe
used in this study
Primer Sequence (5 to 3)
VenSF.............................CTTAGCAGTTTGCGATATTGCCATT
VenSR ............................GCTTTTGAGATAACAATAAGAGCTT
Mg3F ..............................GGTAGCCGCAGCTGCTAAGAT
Mg4R..............................TAGCTACAATAACCACAACT
CFVF..............................CCCAGTTATCCCAAGCGATCT
CFVR .............................CGGTTGGATTATAAATTTTAGCTTGGT
CFVP1............................6-FAM-CATGTTATTTAATACCGCAAa
a The probe was labeled with 6-carboxyfluorescein (6-FAM) phoshoramidite
as the 5 reporter dye and included a nonfluorescent quencher attached to the 3
MGB moiety.
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Assay specificity and sensitivity. The genomic sequence of
the species-specific amplicon from C. fetus subsp. venerealis
strain 98-118432 is described in GenBank under accession no.
AY903214. 5 Taq nuclease primer and probe sequences are
described in Table 2. BLASTn searches identified sequence
identity between the primers, the probe, and the C. fetus subsp.
venerealis plasmid ParA-like protein gene (GenBank accession
no. AY750964). A single base difference was observed between
the ParA-like protein gene sequence and the species-specific
C. fetus subsp. venerealis amplicon that is described here.
By using serial dilutions of C. fetus subsp. venerealis genomic
DNA (gDNA), optimal amplification and fluorescence were ob-
tained using a three-step thermal profile (described in
Materials and Methods) as opposed to the probe manufacturer’s
two-step preferred protocol (results not shown). 5 Taq nucle-
ase assay of genomic DNA from a range of related organisms
and bovine venereal microflora (Table 1) did not produce any
nonspecific amplification. Notably, the morphologically, phe-
notypically, and genetically similar C. fetus subsp. fetus did not
produce a positive assay result in the C. fetus subsp. venerealis
assay.
The viability counts of C. fetus subsp. venerealis dilutions cor-
related well with the hemocytometer counts as indicated in Table
3. The 5 Taq nuclease assay ably detected approximately a single
cell equivalent per assay from heat-lysed spiked preputial smegma
and vaginal mucus preparations and 100 cell equivalents per assay
from urine (Table 4). Culture-based detection was less sensitive
(Table 4), and the C. fetus subsp. venerealis selective media suf-
fered from significant levels of overgrowth by non-Campylobacter-
like organisms, particularly from vaginal mucus. Conventional
PCR assays generally improved upon the sensitivity of culture-
based diagnosis (Table 4), with the greatest improvements being
observed when vaginal mucus specimens were assayed. The 5
Taq nuclease assay provided at least a 10-fold increase in sensi-
tivity compared to those of the other methods that were evaluated
and an improvement of 250-fold or higher compared to that for
selective culture (Table 4).
Sample processing. A number of the samples collected from
healthy animals contained visible contamination with feces, se-
men, and blood. Despite repeated attempts, the conventional
PCR did not yield detectable products from crude cell extracts,
and kit-purified gDNA had to be used as a template for these
assays. The sensitivity limits and quantitative estimates that were
observed by using the 5 Taq nuclease assay did not change in the
presence of potentially inhibitory substances in crude extracts; in
fact, the sensitivity of detection improved slightly compared to
that of gDNA extracts (Tables 4 and 5). Smegma specimens that
were prepared for conventional PCR assay by a commercial DNA
TABLE 3. Colony counts of dilution series prepared from fresh
2-day cultures of C. fetus subsp. venerealis subsequently used
for sensitivity and transport inoculation experiments
Cells/inoculuma Avg colonycount SD
2  103 1,000b NAc
2  102 210 28.28427
2  101 22 4.242641
2  100 2 1.414214
2  101 0 0
a Cells/inoculum are based on an initial direct count using a hemocytometer
followed by serial dilution. Inoculum volume was 100 l/plate.
b The plate contained too many colonies to accurately count, with many col-
onies in physical contact.
c NA, not applicable.
TABLE 4. Detection limits for Campylobacter fetus subsp. venerealis from stored samples determined by selective culture,
conventional PCR assay, and 5 Taq nuclease assaya
Sample
type
Storage
time (days)b
Sensitivity limitc
Selective culture
Assay postenrichment cultured
Conven-
tional
PCR
5 Taq nuclease
assay
5 Taq
nuclease assay
Conventional
PCR QIAamp QIAamp Heat lysis
Smegma 0 25,000 500 5,000e 1,000 10 1
2 25,000 500 5,000e 100 10 1
5 2,500 5,000 5,000 100 1 10
Mucus 0 25,000 50 50 100 10 10e
2 25,000 500 500e 10 10e 1
5 25,000 500 5,000 10 10 1
Urine 0 500 ND f ND ND 10 100e
2 25,000 ND ND ND 10 1
5 25,000 ND ND ND 10 1
a See Table 3 for viability counts of each dilution.
b Smegma and mucus samples for 5 Taq nuclease or conventional PCR assay were stored at ambient temperatures in either PBS or physiological saline. Urine
samples were stored at 4°C. Samples for culture were stored in modified TEM at ambient temperatures.
c Sensitivity limits for both conventional PCR and 5 Taq nuclease assay are given in cell equivalents/assay. Selective culture sensitivity limits are indicated as the
minimum number of cells/inoculum in TEM required to produce Campylobacter-like colonies on subsequently inoculated selective media. Standard deviations on viable
cell counts for each dilution are presented in Table 3.
d DNA was extracted from TEM for 5 Taq nuclease and conventional PCR assay using a commercial kit (QIAamp).
e Positive assay results were possible for the log dilutions below this concentration but were not reliably obtained.
f ND, not done.
VOL. 44, 2006 5 Taq NUCLEASE ASSAY FOR C. FETUS SUBSP. VENEREALIS 941
purification kit appeared to be inhibited relative to vaginal mucus
specimens prepared the same way (Table 4).
Sample storage/transport. Selective culture of vaginal mu-
cus samples for C. fetus subsp. venerealis led to significant levels
of overgrowth by other venereal microflora, limiting identifi-
cation of the slow-growing Campylobacter colonies following
prolonged storage. Urine that had been stored at 4°C for 2 or
more days also proved to have significant levels of contaminat-
ing organisms that were capable of growing on the Campylo-
bacter selective media. Both the 5 Taq nuclease and conven-
tional PCR assays generally improved upon the detection
sensitivity of selective culture following enrichment in TEM.
But detection limits for both PCR-based techniques rose over
the course of 5 days while detection limits for selective culture
either improved or were unaltered (Table 4).
The direct detection of C. fetus subsp. venerealis from clinical
specimens that were not stored in culture medium exhibited
higher sensitivity by both conventional PCR and 5 Taq nucle-
ase assay compared with that of PCR detection postenrich-
ment culture. In fact, estimates of C. fetus subsp. venerealis
numbers in the TEM obtained from 5 Taq nuclease assay
quantitation were shown to drop steadily over the course of
storage (Table 5). The sensitivity of the conventional PCR
improved slightly when specimens were tested at days 2 and
5 (Table 4). A similar trend was generally observed for the
5 Taq nuclease assay results following sample storage. Overall,
5 Taq nuclease assay detection of crude cell lysates prepared
from uncultured clinical material provided the highest level
of C. fetus subsp. venerealis detection despite prolonged
storage or transport at ambient temperatures (for mucus and
smegma). Thus, this protocol was applied for detection of C.
fetus subsp. venerealis for all subsequent animal testing.
Sample collection. The three techniques that were assessed
for the collection of genital mucus specimens from cattle
caused minimal adverse impact and no obvious discomfort
upon the animals. The 10-mm pipette and artificial insemina-
tion infusion pipette both required the application of suction
via a bulb or syringe, often requiring two operators in order to
obtain a suitable sample. The bull rasper was less cumbersome
to use and could be effectively manipulated with one hand.
Three of the eight bulls tested were identified as having natural
C. fetus subsp. venerealis infections, based upon at least one
positive result with selective culture. Selective culture and 5
Taq nuclease assay results for these three animals are presented
in Table 6. Specimens that were collected by using the bull rasper
obtained positive selective culture results for all three bulls, while
those that were collected by using either a pipette or swab pro-
vided selective culture positive results from only one of the three
bulls. The 5 Taq nuclease assay provided positive results for all
three bulls by using each collection technique, and estimates of
cells/ml in the original specimens were highest in the specimens
that were collected with the bull rasper (Table 6).
Field sampling evaluation. Results of the diagnostic culture
and 5 Taq nuclease assays for bull testing (smegma) are pre-
sented in Table 7. All mucus samples were negative by both
culture and 5 Taq nuclease assay; however, 14 were positive by
ELISA. In two herds with four ELISA-positive results, bulls
associated with these herds were identified as positive by the 5
Taq nuclease assay. However, bulls associated with properties
of herds for the remaining 10 ELISA positives were not tested.
Of the 249 bull smegma samples, 13 were positive by culture,
with 9 of these correlating to samples that were positive by the
5 Taq nuclease assay. The four culture-positive specimens
which were 5 Taq nuclease assay negative were confirmed as
false culture positives following 16S rRNA gene sequencing
TABLE 5. Comparison of quantitative estimates
for Campylobacter fetus subsp. venerealis by 5 Taq nuclease
assay of stored samples inoculated with 104 cells
Sample
type
Storage
time (days)a
Avg no. of cells/ml
Assay
postenrichment
cultureb,c
5 Taq nuclease
assay
QIAamp Heat lysis
Smegma 0 15,510 379 1,259
2 3,380 94 1,836
5 0 47 183
Mucus 0 7,905 996 5,282
2 5,948 253 1,838
5 2,764 206 810
Urine 0 NDd 976 693
2 ND 414 426
5 ND 393 776
a Smegma and mucus samples for 5 Taq nuclease or conventional PCR assay
were stored at ambient temperatures in either PBS or physiological saline. Urine
samples were stored at 4°C. Samples for culture were stored in modified TEM at
ambient temperatures.
b DNA was extracted from TEM for 5 Taq nuclease assay using a commercial
kit (QIAamp).
c Quantitative 5 Taq nuclease assay estimates are given in cells/ml.
d ND, not done.
TABLE 6. Diagnostic assay results from successive testing of
naturally infected bulls via different specimen collection tools
Bull Collectiontool
Selective
culturea
Quantitative 5 Taq
nuclease assayb
1 Pipette  1,430
Rasper  2,258
Swab  85
2 Pipette  72
Rasper  1,501
Swab  148
3 Pipette  2,876
Rasper  8,118
Swab  2,910
a , positive culture result; , negative culture result.
b Quantitative 5 Taq nuclease assay estimates are given in cells/ml, which is an
average value calculated from duplicate results.
TABLE 7. Comparison of diagnostic culture and 5 Taq nuclease
assay results from smegma specimens collected from
northern Australian properties
Culture
result
No. of 5 Taq nuclease assay
results that were: Total
Positive Negative
Positive 9 4a 13
Negative 30 206 236
Total 39 210 249
a Confirmed that the four 5 Taq nuclease assay negative-culture positive
isolates were nonspecific positives.
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and conventional subspecies-specific PCR. A further 30 bulls
were negative by culture yet were positive by 5 Taq nuclease.
Of the 16 urine samples collected from 16 smegma-positive
bulls, only 2 urine samples tested positive with the 5 Taq
nuclease assay (results not shown). Chi-square analysis of the
data indicated a strong association between results for the 5
Taq nuclease assay and selective culture (2 29.8; P	 0.001).
Comparison of the proportions that were positive for the 5
Taq nuclease assay (16%) and selective culture (5%) indicated
the 5 Taq nuclease assay is detecting significantly more in-
fected animals (P 	 0.001).
DISCUSSION
Real-time PCR-based techniques, such as 5 Taq nuclease
assays, have been applied to the clinical diagnosis of a wide
range of pathogens from various sources, including C. jejuni
from human stools (24, 43) and Trichomonas vaginalis from
female genital secretions (27). These assays provide improve-
ments in sensitivity and specificity relative to selective culture
and direct microscopic examination, and diagnoses can be ob-
tained in significantly less time. Real-time PCR techniques are
less labor intensive than conventional PCR-based assays, as
there is no need for electrophoretic analysis, and the use of
specific probes offers improved assay sensitivity and specificity
(58). These assays can also provide quantitative measures of
target organisms, providing useful tools to clinicians and
diagnosticians (13, 37, 53). The assay described here is the
first real-time probe-based PCR assay that was developed
for the specific detection and quantification of C. fetus
subsp. venerealis to improve the identification of campylo-
bacteriosis in bull carriers.
The assay designed here was based on a subspecies-specific
PCR target that was shown to previously identify C. fetus
subsp. venerealis successfully, differentiating among 99 strains
of C. fetus subspecies (22). Subsequently, this PCR has dem-
onstrated suitability for subspecies-specific diagnostic and re-
search identification of C. fetus subsp. venerealis (42, 56, 57)
and was therefore considered a suitable target for the devel-
opment of the 5 Taq nuclease assay that is described here. The
sensitivity of the 5 Taq nuclease assay was higher than that of
the conventional PCR assay, as demonstrated during testing of
laboratory-spiked clinical specimens or DNA prepared from
similarly inoculated transport medium. In addition, the con-
ventional PCR did not consistently amplify product from crude
extracts, requiring pure DNA as a template from both clinical
specimens and culture medium. The specificity of this target
fragment for the identification of C. fetus subsp. venerealis was
further confirmed by specific detection by 5 Taq nuclease
assay of all strains of this subspecies that were tested in this
study while also providing considerable improvement on the
conventional PCR assay based on this same target.
The 5 Taq nuclease assay provides several significant im-
provements over conventional culture diagnostic methods. Ap-
proximately one single target cell was sufficient for a positive
result from smegma or cervico-vaginal mucus, whereas a cul-
ture-based diagnosis to isolate Campylobacter-like colonies re-
quired a minimum of 1,000 cells. A method which can with-
stand prolonged transport conditions is critical for the
sampling of animals from extensively grazed cattle regions.
Prolonged transport results in poor culture isolation of C. fetus
subsp. venerealis, and it is recommended that for successful
culture, samples be transported for up to only 48 h prior to
subculture onto selective medium (7). The slow growth and
fastidious nutritional requirements of C. fetus subsp. venerealis
allow rapid overgrowth by more vigorously multiplying con-
taminating organisms. The organism also maintains limited
viability under normal levels of atmospheric oxygen, limiting its
survival during transport (8). In addition, antimicrobial suscep-
tibility differs between isolates of C. fetus subsp. venerealis, with
a majority of isolates showing susceptibility to polymyxin B,
which is used in most Campylobacter fetus selective media (26).
The decline in quantitative 5 Taq nuclease assay estimates of
C. fetus subsp. venerealis numbers during 5 days of simulated
transport in modified Weybridge media illustrates the impact
of these factors on the subsequent isolation of the pathogen.
Therefore, these factors reduce the effectiveness of culture-
based diagnosis, leading to false-negative results for infected
animals as confirmed by our field investigation in this study.
ELISA-based diagnosis of campylobacteriosis has several
significant limitations as a diagnostic tool. It is an indirect
diagnostic method, detecting, rather than the organism itself,
immunoglobulin A antibodies that are specific for the organ-
ism. This immune response can persist for up to 10 months
after infection, long after the infection has been eliminated
(23). As such, it is not an indicator of current infection status,
but rather of exposure within the previous 10 months. The
ELISA is unsuitable for use in diagnosis of bulls, due to a lack
of sufficient titers of antibody in preputial fluids (59). All re-
sults for female cattle tested in this study were negative by
culture and 5 Taq nuclease assays despite the demonstrated
high sensitivity of 5 Taq nuclease assay in spiked mucus sam-
ples. We did, however, identify previously infected females by
using the ELISA, demonstrating the effectiveness of the
ELISA to detect previous exposure. It is feasible that the
seasonal timing of our sample collections did not coincide with
current or recent infection of the female cattle that were sam-
pled for this study. We did not have access to the DIFT used
in Argentina to determine whether this assay is suitable as an
alternative confirmatory diagnostic tool (38).
The direct PCR detection of pathogens in clinical specimens
without culture enrichment is increasingly being applied for
disease diagnosis (1, 12, 16, 39, 46, 47, 54, 60). Although PCR
methods have been developed to differentiate the C. fetus
subspecies following enrichment culture (22, 44), very few
studies describe the direct amplification from clinical speci-
mens (15). Preputial and cervico-vaginal mucus specimens may
contain a range of contaminating materials, including blood,
urine, feces, pus, and semen. These potentially inhibitory ma-
terials can limit the effectiveness of PCR as a reliable diagnos-
tic tool unless adequate DNA purification steps are under-
taken (2, 25). The 5 Taq nuclease assay described here suffers
only minor inhibition in the presence of urine following crude
cell lysis and no significant loss of sensitivity or specificity in the
presence of smegma or mucus, including specimens contami-
nated with the blood, feces, or semen as observed during this
study. Urine is commonly used for the diagnosis of human
venereal diseases in males but is less suitable for similar diag-
noses in females (33, 48). Laboratory-spiked urine specimens
were suitable for 5 Taq nuclease assay, but the suitability of
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urine as a clinical specimen proved less satisfactory than
smegma in our study. Preputial smegma is recommended as
the most reliable clinical sample for the specific diagnosis of C.
fetus subsp. venerealis from bulls. Mucus samples can also be
tested by using the protocols described here, but success is
dependent upon recent colonization of the bacteria in infected
female cattle as described above.
Heat lysis techniques have been successfully applied for the
isolation of template DNA from diagnostic specimens and thus
offer considerable time and labor savings for the routine applica-
tion of DNA-based diagnostics (29, 36, 40, 45, 61). Although
crude sample processing does not remove all potential PCR-
inhibitory substances, 5 Taq nuclease assays appear to be more
robust, enabling successful amplification of target material as
demonstrated in this study. This also simplifies the requirements
for transport from the field to the laboratory, without the need for
complex transport enrichment media. Although, with prolonged
storage of some samples, the sensitivity of detection following
heat lysis diminished slightly, it was determined that amplification
following this crude preparation method proved more sensitive
than that of 5 Taq nuclease assay by using kit-purified templates.
Further transport studies examining the statistical differences of
each processing method and C. fetus subsp. venerealis viability are
required to confirm the preliminary outcomes that were identified
in this study. Nevertheless, the heat lysis processing of clinical
samples, followed by 5 Taq nuclease assay, provided the most
sensitive and practical protocol for the reliable detection of C.
fetus subsp. venerealis for future routine application in diagnostic
laboratories.
Previous studies have demonstrated that the bull rasper could
be an effective tool for the collection of venereal samples for
diagnosis (55). By comparing quantitative 5 Taq nuclease assay
results, we were able to confirm that specimens collected from
infected bulls by using the bull rasper yielded higher estimates of
C. fetus subsp. venerealis cells than did other collection tools. This
was also confirmed by a higher success rate of positive culture
from some specimens. In addition, the bull rasper led to marked
improvements in the ease of specimen collection from both male
and female cattle. Ease of use for the veterinarian, combined with
improved specimen quality and no notable adverse impact upon
the animal, makes the bull rasper a superior tool for the collection
of genital specimens from cattle for the diagnosis of campylobac-
teriosis by either selective culture or 5 Taq nuclease assay. A bull
rasper may be an effective tool for the collection of diagnostic
specimens for other venereally localized organisms, such as
Tritrichomonas fetus.
In summary, the 5 Taq nuclease assay described here is a
reliable, sensitive, and specific detection method for C. fetus
subsp. venerealis in bovine venereal diagnostic specimens, provid-
ing reliable detection of as few as approximately one cell equiv-
alent per assay, and is able to readily discriminate between the
target organism and the phenotypically and genotypically similar
C. fetus subsp. fetus. Specimen collection from male and female
cattle by using a bull rasper has been found to be simple and
efficient, and specimens that are suspended in physiological saline
have proven to be stable during transport at ambient tempera-
tures. Diagnostic specimens can be processed by a simple and
rapid heat lysis technique rather than DNA extraction, with no
loss of sensitivity. Significant improvements in sensitivity and
specificity over those obtained with selective culture-based and
conventional PCR-based techniques was observed, with bull test-
ing proving to be the most reliable specimen for screening herds
for this pathogen. The assay should be suitable for routine use
within diagnostic laboratories with continued use of “gold stan-
dard” culture methods. A multicenter evaluation of the specimen
collection, transport, processing, and assay procedures should
prove valuable. As the detection of C. fetus subsp. venerealis is
significant for trade restrictions, it will be crucial to develop stan-
dardized and robust internal positive and negative control proto-
cols, to develop an alternative sensitive assay to confirm positive
results, and to obtain sequential samples from animals to confirm
test results.
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ADDENDUM IN PROOF
The data summarized in Table 7 were subjected to reanalysis
after the paper was submitted. Some samples were removed
from the analysis, with slight consequent changes to the statis-
tical results. The changes are reflected in the text and do not
affect the interpretation of the results or any subsequent con-
clusions.
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